Related Experiment Video

Updated: Aug 6, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel

Robert F Ozols, Michael A Bookman, Andreas du Bois

    Gynecologic Oncology
    |August 15, 2006
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
    07:54

    Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

    Published on: October 25, 2011

    Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
    09:40

    Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

    Published on: August 2, 2024

    Related Experiment Videos

    Last Updated: Aug 6, 2026

    Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
    04:04

    Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

    Published on: February 12, 2017

    Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
    07:54

    Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

    Published on: October 25, 2011

    Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
    09:40

    Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

    Published on: August 2, 2024

    Related Concept Videos

    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

    Articles linked to this work by shared authors, journal, and citation graph.

    Secondary cytoreduction for ovarian cancer relapse: results from the high surgical quality, multi-center "Surgery in Recurrent Ovarian Cancer Research Consortium (SURROC-CON)".

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

    Treatment and outcome of elderly patients with presumed early ovarian cancer in Germany: real-world observations from the quality-assurance program of the AGO Study Group.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

    Impact of Anatomical Site on RNA-Based Molecular Subtypes in Paired High-Grade Serous Ovarian Carcinoma Samples.

    Cancers·2026

    Constitutional BRCA1 Promoter Methylation in Patients With Ovarian Cancer: Results of the Observational AGO-TR1 Study.

    JCO precision oncology·2026

    Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025

    Phase 3 clinical trials evaluating poly(ADP-ribose) polymerase inhibition plus immunotherapy for first-line treatment of advanced ovarian cancer.

    The oncologist·2025

    Heterogeneity of folate receptor alpha expression and associations with molecular biomarker in ovarian high-grade serous carcinoma: A multicenter Chinese cohort study.

    Gynecologic oncology·2026

    LMOD1 expression and survival in uterine leiomyosarcoma: discordant results in tissue microarrays and whole sections.

    Gynecologic oncology·2026

    Trends in utilization of cervical cancer screening and screening-associated services in a multi-organizational research network in Chicago, Illinois, US.

    Gynecologic oncology·2026

    Phase II study of cabozantinib in recurrent or metastatic cervical cancer after progression on platinum-based chemotherapy (CABOCOL).

    Gynecologic oncology·2026

    Incidence and clinical impact of venous thromboembolism during immunotherapy for gynecologic cancer.

    Gynecologic oncology·2026

    Low-grade serous ovarian cancer: 2026 expert consensus report.

    Gynecologic oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us